BCIM
BIO icon

British Columbia Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

British Columbia Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,727
Closed -$908K – 687
2025
Q1 		$908K Buy
3,727
+17
+0.5% +$5.11K 0.01% 684
2024
Q4 		$1.22M Buy
3,710
+386
+12% +$131K 0.01% 690
2024
Q3 		$1.11M Sell
3,324
-488
-13% -$155K 0.01% 689
2024
Q2 		$1.04M Buy
3,812
+1,256
+49% +$365K 0.01% 700
2024
Q1 		$884K Buy
2,556
+69
+3% +$22.7K 0.01% 739
2023
Q4 		$803K Buy
2,487
+477
+24% +$150K 0.01% 734
2023
Q3 		$720K Buy
2,010
+38
+2% +$14.7K 0.01% 715
2023
Q2 		$748K Hold
1,972
– – 0.01% 715
2023
Q1 		$945K Sell
1,972
-3
-0.2% -$1.4K 0.01% 658
2022
Q4 		$830K Sell
1,975
-218
-10% -$88K 0.01% 680
2022
Q3 		$915K Sell
2,193
-393
-15% -$196K 0.01% 667
2022
Q2 		$1.28M Sell
2,586
-865
-25% -$451K 0.01% 643
2022
Q1 		$1.94M Sell
3,451
-451
-12% -$272K 0.01% 664
2021
Q4 		$2.95M Sell
3,902
-216
-5% -$162K 0.02% 595
2021
Q3 		$3.07M Sell
4,118
-3
-0.1% -$2.25K 0.02% 585
2021
Q2 		$2.65M Buy
4,121
+475
+13% +$289K 0.02% 640
2021
Q1 		$2.08M Sell
3,646
-92
-2% -$54.5K 0.02% 648
2020
Q4 		$2.18M Sell
3,738
-96
-3% -$54.7K 0.02% 638
2020
Q3 		$1.98M Buy
3,834
+252
+7% +$128K 0.02% 598
2020
Q2 		$1.62M Buy
3,582
+1,134
+46% +$500K 0.02% 606
2020
Q1 		$858K Sell
2,448
-2,790
-53% -$1.03M 0.01% 599
2019
Q4 		$1.94M Buy
+5,238
New +$1.85M 0.01% 683

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

British Columbia Investment Management's BIO Position: Q2 2025 in Review

British Columbia Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 3,727 shares — an estimated $908K sold.

British Columbia Investment Management first reported a position in BIO in Q4 2019 and held it in 22 quarters. The position peaked at $3.07M in Q3 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • British Columbia Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • British Columbia Investment Management sold 3,727 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $908K.
  • British Columbia Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 22 quarters.
  • British Columbia Investment Management's Bio-Rad Laboratories Class A position peaked at $3.07M in Q3 2021.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on British Columbia Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.